These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36222290)

  • 21. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model.
    Bilal H; Bergen PJ; Kim TH; Chung SE; Peleg AY; Oliver A; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition and Eradication of Pseudomonas aeruginosa Biofilms by Host Defence Peptides.
    Chen H; Wubbolts RW; Haagsman HP; Veldhuizen EJA
    Sci Rep; 2018 Jul; 8(1):10446. PubMed ID: 29993029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients.
    Feizi S; Cooksley CM; Nepal R; Psaltis AJ; Wormald PJ; Vreugde S
    Pathology; 2022 Jun; 54(4):453-459. PubMed ID: 34844745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of biofilm-forming pathogenic bacteria in the presence of nanoparticles and antibiotic: adaptation phenomena and cross-resistance.
    Mann R; Holmes A; McNeilly O; Cavaliere R; Sotiriou GA; Rice SA; Gunawan C
    J Nanobiotechnology; 2021 Sep; 19(1):291. PubMed ID: 34579731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia-sensitive adjuvant loaded liposomes enhance the antimicrobial activity of azithromycin via phospholipase-triggered releasing for Pseudomonas aeruginosa biofilms eradication.
    Rao Y; Sun Y; Li P; Xu M; Chen X; Wang Y; Chen Y; Deng X; Yu S; Hu H
    Int J Pharm; 2022 Jul; 623():121910. PubMed ID: 35710071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasound-responsive catalytic microbubbles enhance biofilm elimination and immune activation to treat chronic lung infections.
    Xiu W; Ren L; Xiao H; Zhang Y; Wang D; Yang K; Wang S; Yuwen L; Li X; Dong H; Li Q; Mou Y; Zhang Y; Yin Z; Liang B; Gao Y; Wang L
    Sci Adv; 2023 Jan; 9(4):eade5446. PubMed ID: 36696490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfur-Functionalized Fullerene Nanoparticle as an Inhibitor and Eliminator Agent on
    Darabpour E; Doroodmand MM; Halabian R; Imani Fooladi AA
    Microb Drug Resist; 2019 May; 25(4):594-602. PubMed ID: 30461338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3,6-Di(pyridin-2-yl)-1,2,4,5-tetrazine (pytz)-capped silver nanoparticles (TzAgNPs) inhibit biofilm formation of Pseudomonas aeruginosa: a potential approach toward breaking the wall of biofilm through reactive oxygen species (ROS) generation.
    Chakraborty P; Joardar S; Ray S; Biswas P; Maiti D; Tribedi P
    Folia Microbiol (Praha); 2018 Nov; 63(6):763-772. PubMed ID: 29855854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual bioresponsive antibiotic and quorum sensing inhibitor combination nanoparticles for treatment of Pseudomonas aeruginosa biofilms in vitro and ex vivo.
    Singh N; Romero M; Travanut A; Monteiro PF; Jordana-Lluch E; Hardie KR; Williams P; Alexander MR; Alexander C
    Biomater Sci; 2019 Sep; 7(10):4099-4111. PubMed ID: 31355397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound-Enhanced Antibacterial Activity of Polymeric Nanoparticles for Eradicating Bacterial Biofilms.
    Gopalakrishnan S; Gupta A; Makabenta JMV; Park J; Amante JJ; Chattopadhyay AN; Matuwana D; Kearney CJ; Rotello VM
    Adv Healthc Mater; 2022 Nov; 11(21):e2201060. PubMed ID: 36049222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of antibiotic treatment and phagocyte infiltration on development of
    Wu H; Song L; Yam JKH; Plotkin M; Wang H; Rybtke M; Seliktar D; Kofidis T; Høiby N; Tolker-Nielsen T; Song Z; Givskov M
    Front Cell Infect Microbiol; 2022; 12():826450. PubMed ID: 35959369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
    Weldrick PJ; Hardman MJ; Paunov VN
    ACS Appl Mater Interfaces; 2019 Nov; 11(47):43902-43919. PubMed ID: 31718141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Micro/nanosystems and biomaterials for controlled delivery of antimicrobial and anti-biofilm agents.
    Bianchera A; Buttini F; Bettini R
    Expert Opin Ther Pat; 2020 Dec; 30(12):983-1000. PubMed ID: 33078643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic Antifungal Effect of Amphotericin B-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles and Ultrasound against Candida albicans Biofilms.
    Yang M; Du K; Hou Y; Xie S; Dong Y; Li D; Du Y
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670414
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation and study of antimicrobial activity of nanoliposomal meropenem against Pseudomonas aeruginosa isolates.
    Zahra MJ; Hamed H; Mohammad RY; Nosratollah Z; Akbarzadeh A; Morteza M
    Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):975-980. PubMed ID: 27322561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tobramycin Liquid Crystal Nanoparticles Eradicate Cystic Fibrosis-Related Pseudomonas aeruginosa Biofilms.
    Thorn CR; Carvalho-Wodarz CS; Horstmann JC; Lehr CM; Prestidge CA; Thomas N
    Small; 2021 Jun; 17(24):e2100531. PubMed ID: 33978317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm Model.
    Bilal H; Bergen PJ; Tait JR; Wallis SC; Peleg AY; Roberts JA; Oliver A; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment with the Pseudomonas aeruginosa Glycoside Hydrolase PslG Combats Wound Infection by Improving Antibiotic Efficacy and Host Innate Immune Activity.
    Pestrak MJ; Baker P; Dellos-Nolan S; Hill PJ; Passos da Silva D; Silver H; Lacdao I; Raju D; Parsek MR; Wozniak DJ; Howell PL
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30988141
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis of carbon quantum dot-poly lactic-co-glycolic acid hybrid nanoparticles for chemo-photothermal therapy against bacterial biofilms.
    Huang Z; Zhou T; Yuan Y; Natalie Kłodzińska S; Zheng T; Sternberg C; Mørck Nielsen H; Sun Y; Wan F
    J Colloid Interface Sci; 2020 Oct; 577():66-74. PubMed ID: 32473477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.